US, EU Warn About Birth Defect Risk From Dolutegravir
The FDA and EMA have warned about a possible increased risk for neural tube defects in infants born to women who take dolutegravir for HIV during pregnancy. News Alerts …read more
The FDA and EMA have warned about a possible increased risk for neural tube defects in infants born to women who take dolutegravir for HIV during pregnancy. News Alerts …read more
Alendronate, and likely other bisphosphonates, lower cardiovascular event rates in patients treated for osteoporosis following a hip fracture. Medscape Medical News …read more
Bone mineral density divided by body mass index could offer a simple way of predicting fracture risk in those overweight or obese, and may outperform the trabecular bone score. Medscape Medical News …read more
Posthysterectomy surgical site infections fell by more than half after a hospital implemented a seven-step surgical site bundle, a study has found. Medscape Medical News …read more